|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
HORAK IVAN D C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER, NJ 08807 |
EVP, R&D, Chief Scientific Off |
/s/ Craig A. Tooman, Attorney-In-Fact | 01/20/2010 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Shares acquired upon vesting of restricted stock granted to the Reporting Person on January 17, 2008 and reported on a Form 4 filed on January 18, 2008. |
(2) | The Reporting Person previously reported all restricted stock granted to the Reporting Person on January 17, 2008 in Table I of the Form 4 filed on January 18, 2008. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event. |
(3) | Shares acquired upon vesting of restricted stock units granted to the Reporting Person on January 17, 2007 and reported on a Form 4 filed on January 19, 2007. |
(4) | The Reporting Person previously reported all restricted stock units granted to the Reporting Person on January 17, 2007 in Table I of the Form 4 filed on January 19, 2007. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event. |
(5) | Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock and restricted stock units described in this Form 4. |